Paul D'Sylva
2007
In 2007, Paul D'Sylva earned a total compensation of $269K as CEO at HedgePath Pharmaceuticals.
Compensation breakdown
| Option Awards | $52,400 |
|---|---|
| Salary | $156,628 |
| Other | $60,011 |
| Total | $269,039 |
D'Sylva received $156.6K in salary, accounting for 58% of the total pay in 2007.
D'Sylva also received $52.4K in option awards and $60K in other compensation.
Rankings
In 2007, Paul D'Sylva's compensation ranked 7,647th out of 8,700 executives tracked by ExecPay. In other words, D'Sylva earned more than 12.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,647 out of 8,700 | 12th |
Division Services | 1,132 out of 1,256 | 10th |
Major group Engineering, Accounting, Research, Management, And Related Services | 106 out of 121 | 12th |
Industry group Research, Development, And Testing Services | 41 out of 48 | 15th |
Industry Commercial Physical and Biological Research | 35 out of 42 | 17th |
Source: SEC filing on October 30, 2008.
D'Sylva's colleagues
We found two more compensation records of executives who worked with Paul D'Sylva at HedgePath Pharmaceuticals in 2007.